Permira seeks $4 billion for sale of contract drugmaker Cambrex, FT reports

(Reuters) -British private equity firm Permira has put its contract drugmaker Cambrex up for sale, targeting a valuation of as much as $4 billion, the Financial Times reported on Saturday citing people familiar with the matter.

Reuters could not immediately verify the report.

(Reporting by Anusha Shah in Bengaluru; Editing by Aidan Lewis)